Exane BNP Paribas analyst James Picariello upgraded Adient to Neutral from Underperform with a $26 price target. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ADNT: Adient price target lowered to $42 from $46 at BofA Adient price target lowered to $32 from $35 at Morgan Stanley Adient price target lowered to $34 from $37 at Barclays Adient price target lowered to $30 from $32 at Deutsche Bank Adient cuts FY24 revenue view to $14.8B-$14.9B from $15.4B-$15.5B Disclaimer & DisclosureReport an Issue
